Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Pathophysiology of Acute Ischaemic Stroke
Lancet 339:533-536, Pulsinelli,W., 1992
Physical Activity and Stroke in British Middle Aged Men
BMJ 304:597-601, Wannamethee,G.&Shaper,A.G., 1992
Brain Damage from Pertussis Immunization
Am J Dis Child 146:327-331, Camfield,P., 1992
Assessment:DTP Vaccination
Therapeutics and Technology Assessment Subcommittee AAN, Neurol 42:471-4721992., , 1992
Adverse Events Following Pertussis and Rubella Vaccines, Summary of a Report of the Institute of Medicine
JAMA 267:392-396, Howson,C.P.&Fineberg,H.V., 1992
Cluster Headache Syndrome
Postgrad Med 91:96-104, Marks,D.R.&Rapoport,A.M., 1992
Phenytoin and Carbamazepine Decrease Oral Bioavailability of Praziquantel
Neurol 42:492-496, Bittencourt,P.R.M.,et al, 1992
Sumatriptan
Serotonin, Migraine, and Money, Editorial, Lancet 339:151-1522., , 1992
Occipital Lobe epilepsy:Clinical Characteristics, Seizure Spread Patterns, and Results of Surgery
Ann Neurol 31:3-13, Williamson,P.D.,et al, 1992
Parietal Lobe Epilepsy:Diagnostic Considerations and Results of Surgery
Ann Neurol 31:193-201, Williamson,P.D.,et al, 1992
Primary Prevention of Stroke
Lancet 339:344-347, Marmot,M.C.&Poultier,N.R., 1992
Secondary Prevention of Stroke
Lancet 339:724-727, Warlow,C., 1992
Motorcycle Helmet-Use Laws and Head Injury Prevention
JAMA 267:1649-1651, Sosin,D.M.&Sacks,J.J., 1992
Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS
Ann Int Med 117:106-111, 163-1641992., Carr,A.,et al, 1992
The Course of Seizures after Treatment for Cerebral Cysticercosis
NEJM 327:696-701, Vazquez,V.&Sotelo,J., 1992
Cardiac Arrest Due to Partial Epileptic Seizues
Neurol 42:824-829, Liedholdm,L.J.&Gudjonsson,O., 1992
Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992
European Stroke Prevention Study:Effectiveness of Antiplatelet Therapy in Diabetics in Secondary Prevent of Stroke
Stroke 23:851-854, Sivenius,J.,et al, 1992
Trends in Mortality, Morbidity, and Risk Factor Levels for Stroke from 1960 through 1990
JAMA 268:753-759, McGovern,P.G.,et al, 1992
Hypertension and the Brain
Arch Int Med 152:938-945, Phillips,S.J.,et al, 1992
Amount of Smoking Independently Predicts Carotid Artery Atherosclerosis Severity
Stroke 23:693-696, Dempsey,R.J.&Moore,R.W., 1992
Serum Concentrations of Vitamins A and E and Early Outcome after Ischaemic Stroke
Lancet 339:1562-1565, DeKeyser,J.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? Yes
ARch Neurol 49:418-420, Albers,G.W.,et al, 1992
Do NMDA Antagonists Prevent Neuronal Injury? No
Arch Neurol 49:420-421, Buchan,A.M., 1992
DDAVP in the Management of Nocturia in Multiple Sclerosis
Ann Neurol 31:577, Valiquette,G.,et al, 1992
The Effect of 4-Aminopyridine on Clinical Signs in Multiple Sclerosis
Ann Neurol 32:123-130, vanDiemen,H.A.M.,et al, 1992
A Double-Blind, Renadomized, Crossover Trial of Pemoline in Fatigue Assoc with Multiple Sclerosis
Neurol 42:1468-1471, Weinshenker,B.G.,et al, 1992
Preventable Senility:A Call for Action Against the Vascular Dementias
Lancet 340:645-648, Hachinski,V., 1992
Valve Disease Associated with Ergot Alkaloid Use:Echocardiographic and Pathologic Correlations
Ann Int Med 117:50-52, Redfield,M.M.,et al, 1992
Lamotrigine
Lancet 339:1397-1400, Brodie,M.D., 1992
Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992
A Critical Appraisal of Ticlopidine, A New Antiplat Agent, Effectiveness & Clin Indic for Prophylaxis
Arch Int Med 152:1376-1380, Haynes,R.B.,et al, 1992
Carbamazepine-Induced Cardiac Dysfunction, Characterization of Two Distinct Clinical Syndromes
Arch Int Med 152:186-191, Kasarskis,E.J.,et al, 1992
Psychogenic Seizures:Ictal Characteristics and Diagnostic Pitfalls
Neurol 42:95-99, Leis,A.A.,et al, 1992
Presurgical Electroencephalographic Patterns and Outcome from Anterior Temporal Lobectomy
Arch Neurol 49:21-27, Barry,E.,et al, 1992
Value of the Electroencephalogram in Adult Patients with Untreated Idiopathic First Seizures
Arch Neurol 49:231-237, vonDonselaar,C.A.,et al, 1992
Cluster Headache
Neurol 42 (Suppl 2) :22-31992., Mathew,N.T., 1992
Episodic Paroxysmal Hemicrania:Two New Cases and A Literature Review
Neurol 42:964-966, Newman,L.C.,et al, 1992
Pharmacologic Treatment of Childhood Migraine
J Pediatr 120:653-657, Ingarashi,M.,et al, 1992
Emergency Treatment of Headache
Neurol 42 (Suppl 2) :43-44992., Rapoport,A.M.&Silberstein,S.D., 1992
Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992
Symptomatic and Prophylactic Treatment of Migraine and Tension-Type Headache
Neurol 42:16-21, Schulman,E.A.&Silberstein,S.D., 1992
Chronic Daily Headache
Neurol 42:32-36, Sheftell,F.D., 1992
Clinical and EEG Features of Status Epilepticus in Comatose Patients
Neurol 42:100-104, Lowenstein,D.H.&Aminoff,M.J., 1992
A Correlative Triad of Gadolinium-DTPA MRI, EDSS, & CSF-MBP in Relapsing MS Treated with High-Dose Intravenous Methylprednisolone
Neurol 42:63-67, Barkhof,F.,et al, 1992
Gray Matter Heterotopias:MR Characteristics & Correlation with Develop & Neurologic Manifest
Radiology 182:493-499, Barkovich,A.J.&Kjos,B.O., 1992
Assessment:Magnetoencephalography (MEG)
Report of Therapeutics & Tech Assess Subcommittee of AAN, Neurol 42:1-492., , 1992
Temporal Lobectomy for Intractable Epilepsy in Patients Over Age 45 Years
Neurol 42:662-665, McLachlan,R.S.,et al, 1992
'De Novo'Absence Status of Late Onset:Report of 11 Cases
Neurol 42:104-110, Thomas,P.,et al, 1992